Biomarker aids diagnosis of metastatic breast cancer

03/14/2013 | PhysiciansBriefing.com

Circulating tumor DNA may be a better indicator of metastatic breast cancer than circulating tumor cells or cancer antigen 15-3. Circulating tumor DNA allowed for the detection of 29 of 30 cases, researchers said, and the biomarker provided the earliest measure of response to therapy. The research was reported in the New England Journal of Medicine.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX